Immunomodulation of interleukin-2 by cyclophosphamide: a phase IB trial.
Abrams JS, Eiseman JL, Melink TJ, Sridhara R, Hiponia DJ, Bell MM, Belani CP, Adler WH, Aisner J.
Abrams JS, et al.
J Immunother Emphasis Tumor Immunol. 1993 Jul;14(1):56-64. doi: 10.1097/00002371-199307000-00008.
J Immunother Emphasis Tumor Immunol. 1993.
PMID: 8399071
Clinical Trial.